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Zinc and Iron Homeostasis:
Target-Based Drug Screening as
New Route for Antifungal Drug
Development
Claudia Simm 1,2* and Robin C. May 1
1 School of Biosciences, Institute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom,
2Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia
The incidence of fungal diseases is on the rise and the number of fatalities is still
unacceptably high. While advances into antifungal drug development have been made
there remains an urgent need to develop novel antifungal agents targeting as-yet
unexploited pathways, such as metal ion homeostasis. Here we report such an approach
by developing a metal sensor screen in the opportunistic human fungal pathogen
Candida albicans. Using this reporter strain, we screened a library of 1,200 compounds
and discovered several active compounds not previously described as chemical entities
with antifungal properties. Two of these, artemisinin and pyrvinium pamoate, have been
further characterized and their interference with metal homeostasis and potential as novel
antifungal compounds validated. Lastly, we demonstrate that the same strain can be
used to report on intracellular conditions within host phagocytes, paving the way toward
the development of novel screening platforms that could identify compounds with the
potential to perturb ion homeostasis of the pathogen specifically within host cells.
Keywords: Candida, antifungals, high throughput drug screening, zinc homeostasis, iron homeostasis,
artemisinin, pyrvinium pamoate
INTRODUCTION
The incidence of life-threatening fungal infections is increasing dramatically, primarily due
to the rise in patients with impaired immunity through conditions like HIV/AIDS, primary
immune deficiency, cancer chemotherapy or organ transplantation (Roemer and Krysan, 2014).
Most current antifungal drugs were developed in the 1980s and target either ergosterol or
cell wall biosynthesis. Limited efficacy and substantial host toxicity mean that systemic fungal
disease is amongst the deadliest human infection, exhibiting mortality rates in excess of 50%.
Together, the leading fungal pathogens in humans (Candida albicans, Aspergillus fumigatus, and
Cryptococcus neoformans) cause over two million infections, and a million deaths, per year
(Pianalto and Alspaugh, 2016). In addition, increasing resistance toward these “old drugs,” as
well as the emergence of intrinsically resistant fungal pathogens such as Candida auris means
that the development of new therapeutic strategies for this group of organisms is paramount
(Chowdhary et al., 2017).
The understanding of fungal pathogenesis has increased, and new virulence factors have been
identified over the recent years (Perfect, 1996; Nicola et al., 2018). So far none of these fungal
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virulence genes have been exploited as a druggable target in
Cryptococcus spp. and Candida spp. (Wong et al., 2014).
Lately, much attention has been paid to gene products
involved in ion homeostasis (Li et al., 2018). Several
metal-regulated or metal-regulatory genes such as PRA1,
FTR1, CSR1, andHAP43 have been identified as virulence factors
and loss of function of these genes attenuates virulence in animal
models (Staats et al., 2013; Ding et al., 2014; Gerwien et al., 2017;
Skrahina et al., 2017).
Inside host phagocytic cells, pathogenic organisms face
extreme iron and zinc limitation. These essential metal ions are
actively withheld by the host by tightly regulating the level of
labile ions to very low concentrations, thereby limiting their
availability to microbial pathogens (Potrykus et al., 2014). The
host protects metal ions by compartmentalization or through
the activity of metal-binding proteins such as hemoglobin,
transferrin, calprotectin, and lactoferrin (Philpott, 2006; Gerwien
et al., 2017). Invasive fungi have to scavenge these ions in order
to secure sufficient levels of iron and zinc to proliferate under
limiting conditions. Microorganisms use an array of high- and
low-affinity metal transporters and their expression is regulated
by metal-responsive transcription factors. Those include the C.
albicans zinc-responsive transcription factor Csr1/Zap1 and the
iron-responsive counterparts Sef1 and Hap43 (Kim et al., 2008;
Noble, 2013).
Zinc is a critical micronutrient for fungal growth and
the regulation of its uptake and sequestration has been well
studied in the model yeast S. cerevisiae. This budding yeast
has both high (i.e., Zrt1) and low (i.e., Zrt2) affinity zinc
transporters which are regulated by the Zap1 transcription
factor. Zap1 recognizes zinc-responsive elements in the promoter
regions of zinc-regulated genes (Eide, 2003). In metal replete
conditions, this transcription factor inhibits expression of Zap1-
regulated genes while transcription is triggered under zinc
deficiency conditions. Homologous zinc transporters as well as
their transcriptional regulators are present in a wide range of
pathogenic fungi (Jung, 2015). C. albicans also contains two
zinc uptake transporters Zrt1 and Zrt2. Unlike S. cerevisiae, in
C. albicans these zinc uptake proteins cannot be described as
low and high affinity transporters, but their expression is pH-
dependent (Crawford et al., 2018). While Zrt1 facilitates uptake
under neutral to alkaline conditions, Zrt2 is the main uptake
transporter in Candida over a wider pH range. It is essential for
infection and a ZRT2 deletion mutant showed reduced virulence
in a murine candidiasis model. Transcription level of both ZRTs
are regulated by the transcription factor Csr1 (Kim et al., 2008;
Böttcher et al., 2015). A C. albicans csr1/csr1 mutant showed
severe defects in growth and filamentation and Csr1 is described
as an important virulence factor.
Most fungal organisms rely on two iron uptake mechanisms:
(1) a membrane-bound reductase/permease complex and (2)
internalization of extracellular Fe3+-siderophore complexes
(Philpott, 2006). Siderophores are small high-affinity iron
chelators. The fungal pathogens Cryptococcus spp. and Candida
spp. cannot synthesize their own siderophores but rather encode
siderophore–iron transporters and can utilize siderophores
synthesized by bacteria or other fungi (Heymann et al., 2002).
The reductive iron uptake pathway is best characterized in S.
cerevisiae, where iron uptake is facilitated through a Fet3/Ftr1
complex (Kosman, 2003). Fet3 is a multi-copper ferroxidase
which reduces ferric iron to ferrous iron which is taken up into
the cell by the ferrous permease Ftr1. The deletion of the FTR1
homologs in C. albicans (CaFTR1) and C. neoformans (CFT1)
lead to impaired iron acquisition and attenuated virulence in
a mouse model (Ramanan and Wang, 2000; Jung et al., 2009).
Both high affinity iron transport pathways are strictly regulated
depending on metal availability in the surrounding environment.
Sef1 and Hap43 are main iron uptake regulators under iron
limiting conditions (Chen et al., 2011; Skrahina et al., 2017).
In this study we sought to identify drugs that disrupt essential
micronutrient, zinc and iron homeostasis in fungal pathogens
by interfering with metal uptake, transcriptional regulation or
sequestration processes within pathogens such as C. albicans.
We designed fluorescence-based zinc and iron sensors by
fusing zinc and iron responsive promoter elements to GFP or
dTomato reporters. We show that the resulting metal sensors
are amenable to high throughput drug screening and respond
rapidly to changes in micronutrient limitation. We used C.
albicans harboring the metal sensors to screen 1,200 compounds
of the Prestwick Chemical library for novel antifungals. The
total hit rate did not exceed 2.5%, indicative of a target-specific
high throughput platform. Hit compounds were validated via
secondary assays for a metal-dependent mode of action, whilst a
phagocyte-based assay demonstrated the feasibility of using these
promoter-reporter sensors for the identification of drugs with
increased anti-microbial activity in phagocytes.
Taken together, this study presents a method for the
identification and verification of new antifungal drugs targeting
the perturbation of zinc and iron homeostasis using C. albicans
as a model fungal pathogen.
METHODS
Strains and Media
The C. albicans CaI4 strain ura3::imm434/ura3::imm434
iro1/iro1::imm434 was used in this study and grown in YPD at
30◦C. Yeast transformants carrying the zinc or iron sensor were
plated on YNB plates without uridine. Positive transformants
were grown in liquid YNB-ura and all high throughput screens
and validation experiments were carried out in phenol red-free
and serum-free RPMI-1640 (R8755, Sigma). The medium was
buffered with 3.5% MOPS and the pH was adjusted to either pH
5.6 for growth at 30◦C (yeast) or to pH 7.2 for growth at 37◦C
(hyphae). The cloning of the metal sensors was carried out in
Escherichia coli strain DH5α (New England Biolabs) which was
grown in LB with or without ampicillin.
Generation of the Zinc and Iron
Promoter-Reporter
Standard cloning procedures were used for the DNA
manipulation and transformation of E. coli. The genes of
GFP and dTomato were amplified from plasmid template pGFP-
RH (gift from Rebecca Hall, Hall et al., 2011) and genomic DNA
from a dTomato expressing Candida strain (gift from Rebecca
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Hall), respectively. The promoter sequences of ZRT2 and HAP43
were amplified from genomic DNA from CaI4. All primers are
shown in Table 1. PCR products were digested with relevant
restriction enzymes (Table 1) and inserted into pGFP-RH. The
resulting plasmids were linearized with the restriction enzyme
XhoI before integration into the URA3 site of the CaI4 genome
using the lithium acetate protocol. Transformants were plated
out onto YNB-ura and grown for 2–3 days before testing for GFP
and dTomato expression.
Validation of Assay Conditions
Transformants carrying the zinc or iron sensor were inoculated
into RPMI medium (pH 5.6 or 7.2) and grown with or without
metal chelators DTPA, EDTA, and TPEN (Sigma) for up to 24 h
at 30 or 37◦C, respectively. Cells were adjusted to a starting cell
density OD600 of 0.05 and suspensions were transferred into
black, clear bottom 96-well plates (Corning CLS3603, Sigma).
Cell density absorbance at 600 nm, GFP (485-12 ex/520 em) and
dTomato (544 ex/620-10 em) expression weremeasured every 2 h
using a FLUOStar Omega (BMG labtech) plate reader.
High Throughput Screen and Hit
Compound Validation
The Prestwick Chemical library containing 1200 FDA-approved
compounds was used for this screen. The 10mM compounds
stocks were diluted in 40% DMSO to a concentration of 400µM
in intermediate plates. Five microliters of the intermediate
plate solutions were spotted into black clear bottom 96-well
assay plates (Corning CLS3603, Sigma) using a Microlab Star
Liquid Handling System (Hamilton). Immediately 200 µl of C.
albicans suspension adjusted to a cell density OD600 = 0.05
in RPMI, pH 7.2 was added to the assay plates. A negative
DMSO and a positive 5µM TPEN control was added to each
assay plate. For the high throughput screen Candida expressing
the Zrt2promoter-dTomato and Hap43promoter-dTomato were
used. The cell density (OD600) and dTomato (544ex/590 em)
TABLE 1 | Primer sequences and restriction sites.
Primer Sequence Restriction site
CaZrt2prom 5′ CGCG GCGGCCGC
ATATTGTGTAATTTTACATTT
NotI
CaZrt2prom 3′ CGCG ACTAGT
TCAGTGTTAACTAATTC
SpeI
Hap43prom 5′ CGCG GCGGCCGC
AGAATGTTACTAGATTCT
NotI
Hap43prom 3′ CGCG ACTAGT
GTTCAAATTGAAATTC
SpeI
dTomato 5′ CGCG ACTAGT
ATGGTTTCAAAAGGTG
SpeI
dTomato 3′ CGCG GGATCC
TTATTTATACAATTCATCC
BamHI
GFP 5′ CGCG ACTAGT
ATGTCTAAAGGTGAAG
SpeI
GFP 3′ CGCG GGATCC
CTAGCTTATTTGTACAA
BamHI
were measured after 14 h of incubation at 37◦C without shaking
using a POLARStar Omega, (BMG labtech).
Identified hit compounds were purchased from Sigma
and serially diluted as indicated. Cultures of C. albicans
transformed with Zrt2promoter-dTomato, Hap43promoter-
dTomato, Zrt2promoter-GFP, and Hap43promoter-GFP were
diluted to a cell density OD600 = 0.05 in RPMI, pH 5.6 or 7.2
and incubated at 30 or 37◦C, respectively. Cell density, GFP, and
dTomato fluorescence were measured between 12 and 14 h.
Time-Lapse Experiments
Candida cell expressing the zinc or iron promoter reporter were
grown in black, clear bottom 96-well plates (Corning CLS3603,
Sigma) at room temperature in RPMI, pH 5.6 for 24 h with or
without drug treatment, and GFP and dTomato fluorescence was
monitored using the JuLI Stage Real-Time Cell History Recorder
(NanoEnTek, Korea). Images were taken every hour for 24 h
using the transmitted light, GFP (466-40 ex/525-50 em) and RFP
(525-50 ex/580LP em) channel at a 20-fold magnification.
Toxicity Assay
The lung epithelial cell line A549 was grown in RPMI-1640
(21875, Gibco) with 10% FBS and seeded at 4,000 cells per well
in a 96-well plate. After 1 day of incubation at 37◦C, 5% CO2
cultures were treated with a serial dilution of selected drugs and
incubated for a further 48 h. Fifteen microliter of CellTiterBlue
(Promega) was added to each well including medium only
controls and incubated for 2–4 h and fluorescence (544 ex/580
em) was immediately measured using a plate reader (FLUOStar
Omega, BMG labtech).
Measurement of Total Metal Content
C. albicans cell cultures were grown in YNB for 16 h with or
without drug treatment. Cells were harvested and washed in ice-
cold 1mM EDTA. The cell pellet was then dried in a vacuum
concentrator (Concentrator 5301, Eppendorff) and its dry weight
was measured. The dry cell pellet was digested in 200 µl 65%
nitric acid (Suprapur, Merck) and 15 µl H2O2 at 70
◦C for
30min. The digest was filled up to a total volume of 5ml with
distilled water and subjected to inductively coupled plasma—
optical emission spectrometry ICP-OES measurement using an
ICP-OES spectrometer (OES Optima 8000 and S10 Autosampler,
Perkin Elmer).
Measurement of Labile Zinc
C. albicans cell cultures were grown in RPMI, pH 5.6 at 30◦C
for 16 h with or without drug treatment. The zinc dye FluoZin-
3AM (ThermoFisher) was added to the samples at a final
concentration of 5µM and incubated for a further 30min at
30◦C. Cells were washed twice in PBS and fluorescence was
immediately measured using a flow cytometer (NxT Attune,
ThermoFisher). The FluoZin-3AM fluorescence was measured
using the FITC channel.
Candida Phagocytosis Assay
J774 macrophages grown in low glucose DMEM (D5546, Sigma)
with 10% FBS were plated at cell density of 1 × 105 cells per
well onto sterile 18mm glass microscopy cover slips (VWR) in
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a 24-well plate and incubated at 37◦C with 5% CO2 overnight.
Macrophages were activated by adding 1ml of serum-free
DMEM medium containing 15 µl of a 10µg/ml phorbol 12-
myristate 13-acetate (PMA) stock (P8139, Sigma). Macrophages
were incubated for 1 h at 37◦C and 5% CO2. Immediately
medium was removed and cells were washed twice in PBS.
Overnight cultures ofC. albicans containing the fluorescentmetal
sensors were washed in PBS and adjusted to a cell density of either
2× 106 or 5× 106 cells/ml. Nine hundred and fifty microliter of
fresh serum-free DMEM with 50 µl of the Candida suspension
was added to the macrophages and incubated for a further hour
at 37◦C and 5% CO2. After the incubation the medium was
removed, cells were washed twice with PBS followed by fixation
in 4% paraformaldehyde for 10min. The fixative was removed,
cells were washed twice in PBS and mounted onto microscopy
slides with Fluoromount (F4680, Sigma). Images were taken at
40×magnification using a Zeiss Axio observer microscope using
DIC, GFP, and Texas Red channel. Images were acquired through
Axio Zen software (Zeiss).
RESULTS
Metal Chelators Increase GFP
Fluorescence in a Time-Dependent Manner
For the development of metal responsive reporter-promoter
constructs, the promoter sequences of the zinc-regulated ZRT2
and the iron-regulated HAP43 of C. albicans were fused to GFP
or dTomato. In previous studies the expression of these genes was
up-regulated under zinc or iron starvation and essential for metal
uptake under metal-limiting conditions (Jung, 2015; Skrahina
et al., 2017; Crawford et al., 2018). We therefore expected
an increase in fluorescence expression when labile intracellular
concentration of zinc and iron decreased. The zinc and iron
promoter-reporter constructs were integrated into the genome
of C. albicans to avoid copy number effects associated with
episomal expression. Since the identification of hit compounds
relies on the ability of Candida sensor strains to detect metal
limitation, we grew them in the presence of metal chelators
(Figure 1). The expression of GFP in Candida containing the
Zrt2prom-GFP sensor was significantly increased 12 h after
transfer into chelator containing medium. The chelators DTPA
and TPEN strongly induced GFP under yeast growth conditions
(RPMI, pH 5.6 and 30◦C) whereas EDTA showed only weak
induction (Figure 1A). TPEN caused the biggest increase in
fluorescence under hyphal growth conditions (RPMI, pH 7.2
and 37◦C) while both DTPA and EDTA showed a much weaker
GFP expression (Figure 1B). The highest GFP expression was
observed between 12 and 14 h, in close agreement with previous
studies in which Saccharomyces cerevisiae as well as C. albicans
could sustain proliferation for eight cell division cycles (e.g.,
12–14 h) without external zinc (Simm et al., 2007; Duncan
Wilson, personal communication). This time frame was also
associated with the highest z’-factors and therefore used as the
end point read-out for the high-throughput assay. At later time
points the signal window declines, something that is particularly
prominent under yeast growth condition. At these later time
points, cells deplete their internal zinc storage and therefore
experience zinc starvation, associated with an induction of
GFP expression which in turn effects the dynamic range of
the signal window. A sharper decline of the signal window
is seen in yeast cultures which reach stationary phase earlier
than hyphae.
In order to test if all promoter-reporter constructs generated
for this study are induced similarly we observed growth and
fluorescence expression in a Real-Time Cell History Recorder
(NanoEnTek, Korea) for 24 h. Due to the lack of a temperature-
controlled incubation chamber in the Cell History Recorder
cells had to be grown at room temperature. Fluorescence was
initially triggered at 6 h and fully expressed by 12 h for all
transformed strains tested (Figure 2, Supplementary Movies).
No fluorescence was seen for Candida transformed with
a control plasmid (Figure 2). Additionally, fluorescence in
untreated vs. treated condition was investigated. Only a
very small population of untreated yeast expressed dTomato
(Supplementary Movie 3) or GFP (data not shown) after 6 h
of growth. In contrast to the metal chelator treated samples
only a marginal increase in fluorescence intensity was observed
thereafter. Metal chelator treated samples steadily increased
FIGURE 1 | A culture of Candida albicans containing the Zrt2prom-GFP promoter-reporter construct was adjusted to a cell density OD600 = 0.05 and grown in either
(A) RPMI, pH 5.6 at 30◦C or (B) RPMI, pH 7.2 at 37◦C. Cells were grown in absence or presence of indicated metal chelator and cell density and GFP expression
was measured every 2 h.
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FIGURE 2 | Candida albicans containing the metal promoter-reporter construct or a control plasmid were adjusted to a cell density OD600 = 0.05 and grown in
RPMI, pH 5.6 at room temperature with 5µM TPEN for 24 h. Images were taken by JuLI Stage Real-Time Cell History Recorder (NanoEnTek, Korea) every hour.
Images shown were taken at 16 h after treatment.
fluorescence, suggesting that the GFP and dTomato signal is a
response to lower level in iron and zinc availability and thus
that these strains represent specific sensors for ametal-dependent
high throughput screen.
Screening of the Prestwick Chemical
Library
We screened the established Prestwick Chemical library which
consists of 1200 FDA-approved small compounds to test
the potential of the zinc and iron sensor to identify novel
antifungal compounds. The original idea of a double sensor
strain containing the green fluorescent zinc sensor (Zrt2prom-
GFP) and the red fluorescent iron sensor (Hap43prom-dTomato)
had to be abandoned. Due to the brightness of the dTomato
fluorescence its signal bled into the GFP channel in plate
reader experiments. Therefore, the zinc and iron sensor had
to be analyzed separately. For the high throughput screen
the Zrt2prom-dTomato and Hap43prom-dTomato promoter-
reporter strains were used since the z’-factors were higher than
those of Zrt2prom-GFP and Hap43prom-GFP strains. Candida
strains were grown at 37◦C for 12–14 h, since these conditions
resulted in the best z’-factor (>0.5). Moreover, a temperature
of 37◦C has greater biological relevance than growth at 30◦C.
All compounds were tested at a final concentration of 10µM
in 1% DMSO. Every assay plate contained a negative control
(1% DMSO) which set the baseline of dTomato expression and
a 5µM TPEN positive control to assess quality control and
plate-to-plate variability.
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We selected a cut-off value of 1.8-fold for expression of
dTomato compared to the DMSO baseline level, resulting in
an overall low hit rate of 29 compounds (2.4%) for zinc and
27 compounds (2.2%) for iron (Figures 3A,B). The number of
drug hits is much reduced compared to the S. cerevisiae metal-
sensor screen which was conducted at a compound concentration
of 100µM (Simm et al., 2011), suggesting that this higher
concentration may have triggered significant off-target effects.
The z’-factor over all 15 plates for the zinc and iron screen
was 0.58 and 0.52, respectively and therefore met the criteria
for an excellent assay with a large separation of positive and
negative signal readouts (Iversen et al., 2006). We grouped the
hits from this screen according to their therapeutic classes, with
most compounds being classified as antibacterial or antifungal
(Figures 3C,D). These compounds were of less interest to us
due to their previous use in antimicrobial therapy. We instead
turned our focus on the compounds with no previous association
with antimicrobial properties. Additionally, two small molecules
(Merbromin and Doxorubicin) which showed a very high
dTomato signal in the high throughput screen were excluded as
false-positives due to their red color and high autofluorescence.
We further restricted the hit compound list by excluding directly
fungicidal compounds that resulted in a viability of <10%, since
metal-dependent regulatory processes are strongly disturbed in
dying cells. A full summary of all hit compounds can be found
in Supplementary Table 1. All compounds that were exclusively
defined as hits for only zinc or only iron are listed in Table 2.
Validation of Selected Hit Compounds
Next, we performed dose response analyses to validate lead
compounds that have not previously been reported to have
antimicrobial activity. Tenatoprazole did not confirm as a hit
FIGURE 3 | Summary of high throughput metal sensor screen. The total hit distribution and therapeutic classes for the zinc sensor (A,C) and iron sensor (B,D)
are shown.
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and Nifurtimox only triggered increased fluorescence expression
at concentrations of 0.25–1µM which is far below the initial
screening concentration. Both compounds were not followed
up further. The hits artemisinin, an antimalarial, as well as
pyrvinium pamoate, an anthelmintic, were selected for further
validation studies. Pyrvinium pamoate showed autofluorescence
due to its inherent red color. However, its intrinsic fluorescence
was smaller than the dTomato fluorescence readout. In order
to avoid any interference of background fluorescence all
dose response experiments were carried out with the GFP
metal sensors where pyrvinium pamoate did not show any
autofluorescence. Figure 4 shows the dose response curves
for both compounds, artemisinin and pyrvinium pamoate,
with a significant increase in GFP expression from 7.5µM
for artemisinin and 1µM for pyrvinium pamoate. We then
tested the toxicity of these compounds in a human cell line.
The lung epithelial cell line A549 was grown with increasing
concentrations of artemisinin and pyrvinium pamoate for
48 h (Figure 5). While only a slight reduction in metabolic
activity could be observed at 10µM Artemisinin, pyrvinium
pamoate started to have growth limiting effects at much lower
concentration with an IC50 of 5 µM.
Artemisinin and Pyrvinium Pamoate Effect
Intracellular Zinc and Iron Level
In order to test the specificity of the metal sensors we measured
the intracellular metal content upon drug treatment. The total
zinc and iron concentration were determined by ICP-OES. For
TABLE 2 | HTS compounds unique for zinc or iron.
Zinc Iron
Nifurtimox Voriconazole
Tenatoprazole Miconazole
Clofazimine Quinacrine HCl
Pemirolast potassium Propidium iodide
Artemisinin
this experiment cells had to be grown in YNB rather than RPMI,
since the very low basal metal concentration in the latter medium
is too close to the detection limit of the ICP-OES instrument.
Artemisinin has no effect on total intracellular zinc (Figure 6A)
but caused a small but significant reduction in intracellular
iron (Figure 6B) at 1µM and a further significant decrease
at 10µM when compared to control conditions. Pyrvinium
pamoate reduces the total intracellular zinc concentration to a
level below seen for the zinc chelator TPEN at concentrations
of 0.5 and 1µM (Figure 6A). This effect is lost when reducing
the concentration to 0.1µM. It also significantly reduces
intracellular iron level at all concentrations tested (Figure 6B).
Again, drug concentrations of 0.5 and 1µM pyrvinium pamoate
drop metal concentrations below those measured for the metal
chelator EDTA.
Next, we wanted to correlate the obtained total intracellular
zinc and iron concentrations with labile intracellular zinc and
iron level by using metal fluorescent indicators. By staining
C. albicans wildtype with the zinc dye Fluo-Zin3AM a small
but significant shift in fluorescence intensity could be observed
for all artemisinin-treated samples, suggesting that labile zinc
concentrations were decreased (Figure 7A). An increase in
fluorescence intensity of nearly two orders of magnitude
could be detected in samples treated with 1 and 0.5µM
pyrvinium pamoate (Figure 7B), which correlates strongly with
the reduction in total cellular zinc seen for these concentrations.
Unfortunately, the iron probe experiment was unsuccessful and
therefore only data for labile zinc using can be shown at
this point.
Phagocytosis of Candida Metal Sensor
Strains
The zinc and iron promoter-reporter strains can provide a
powerful tool for many applications and thus we tested their
application in a phagocytosis assays using J774 macrophages.
Candida carrying Zrt2prom-GFP or Hap43prom-dTomato were
engulfed bymacrophages within 1 h and showed good expression
of the fluorescent reporter within these host cells (Figures 8A,B).
FIGURE 4 | A culture of the promoter-reporter strains of Candida albicans were adjusted to a cell density OD600 = 0.05 and grown in RPMI, pH 7.2 at 37
◦C for 16 h
with indicated concentrations of (A) Artemisinin or (B) Pyrvinium pamoate when cell density (OD600) and GFP fluorescence was measured. The values are the means
± standard deviation (SD) of at least 3 independent experiments.
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Due to the lack of a double zinc/iron promotor-reporter
strain, a 1:1 mixture of C. albicans transformed with either
Hap43prom-dTomato or Zrt2prom-GFP was used to monitor
changes in fluorescence for both sensors in one macrophage cell
(Figure 8C). Candida carrying either metal sensor were detected
within one macrophage without any interferences seen in the
plate reader experiments.
The addition of artemisinin or pyrvinium pamoate to the
inoculum did not alter GFP or dTomato expression (data not
shown). However, the drug treatment could only be applied for
1 h (since Candida filaments and destroys the host cell after that
time point) a time frame that might be too short for the impact
of the drug to be revealed. Preliminary data suggest that the
metal sensor fluorescence in Candida within the macrophages is
FIGURE 5 | Cell cultures of A549 epithelial cells were treated with indicated
concentrations of Artemisinin and Pyrvinium pamoate for 48 h. Metabolic
activity was determined by CellTiterBlue assay. The values are the means ±
SD of at least 3 independent experiments.
higher than in those not phagocytosed (Figures 8A,B). Again, a
longer incubation of the pathogen with macrophages is needed to
fully evaluate this finding. The introduction of a mutant partially
impaired in hyphae formation (1cph1) did not sufficiently extent
the assay time and hyphae formation was observed at 4 h after the
inoculation of Candida to macrophages (data not shown).
DISCUSSION
Currently, only three distinct antifungal drug classes—azoles,
polyenes, and echinocandins—are in current clinical use.
This is greatly surpassed by the number of drugs available
for viral and bacterial diseases. While improvements in
antifungal drug development have been made, none of the
current antifungal compounds act on fungal-specific targets
such as virulence factors. The most common virulence factors
are involved in processes such as adhesion, morphogenesis,
phenotypic switching, biofilm formation, and metabolic
adaptation (Mayer et al., 2013; Gerwien et al., 2017).
The latter includes trace metal acquisition which has been
described as a promising pathway for novel antifungal drug
development (Simm et al., 2011; Bernardo et al., 2014; Li
et al., 2018). Exploiting pathogen specific virulence factors
would exert less selective pressure on pathogenic fungi, thereby
minimizing effects on the host system and reducing the
selective pressure for drug resistance compared to growth
inhibiting drugs.
We developed a high throughput screen to identify previously
unknown antifungal drugs. Unlike the classical approach, this
screen will not identify compounds with fungicidal properties,
but is designed to target zinc and iron homeostasis in the
opportunistic fungal pathogen C. albicans. Drugs identified in
this way will increase fungal susceptibility to host nutritional
immunity and can strengthen existing monotherapies with
known antifungal agents.
The screening of the Prestwick Chemical library with 1200
FDA approved small molecules revealed 29 and 27 potential
FIGURE 6 | Candida albicans cultures were adjusted to a cell density OD600 = 0.01 and grown for 16 h in YNB with indicated compound concentrations and total
cellular (A) zinc and (B) iron content was measure via ICP-OES. The values are the means ± SD of at least 2 independent experiments with 2 technical replicates.
Changes of total metal content was compared to control conditions and p-values were calculate by unpaired, two tailed t-test (ns p > 0.05, *p ≤ 0.01, **p ≤ 0.001,
***p < 0.001).
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FIGURE 7 | Candida albicans were adjusted to a cell density OD600 = 0.05 and grown in RPMI, pH 5.6 at 30
◦C for 16 h with (A) Artemisinin (10µM—orange,
5µM—blue, 1 µM—green, or DMSO—red) or (B) Pyrvinium pamoate (1µM—orange, 0.5µM—blue, 0.1µM—green, or DMSO—red). Cells were stained with 5µM
FluoZin-3AM and labile zinc concentration was measured via flow cytometry.
FIGURE 8 | The phagocytosis of Candida albicans transformed with (A) the Zrt2prom-GFP, (B) Hap43prom-GFP or (C) 1:1 mixture of Candida albicans transformed
with either Hap43prom-dTomato or Zrt2prom-GFP was monitored at 1 h after exposure to J774 cells and images were obtained with a Zeiss Axio microscope using a
40× objective.
hits perturbing zinc or iron homeostasis, respectively (Figure 3).
Most of themwere already classified as antibacterial or antifungal
drugs, e.g., azoles (Supplementary Table 1). Azole antifungals
can bind metals due to their chemical structure and have been
shown to interfere with metal homeostasis (Seward et al., 2006;
Silva et al., 2011). Five compounds had not previously been
investigated for antifungal therapy and were pursued further.
After secondary validation, two compounds (artemisinin and
pyrvinium pamoate) emerged as lead compounds. Artemisinin
is primarily described as an antimalarial drug but recently its
pharmacological properties have been extended to antitumor,
antibacterial, antiviral, antileishmanial, antischistosomiatic, and
herbicidal activities (Krishna et al., 2008; Liu et al., 2019).
While its exact mode of action is not yet fully understood,
several studies investigated ferrous iron binding as a plausible
mechanism for this drug (O’Neill et al., 2010; Shandilya
et al., 2013). In line with this, we observed a reduction in
total intracellular iron as well as labile zinc with this drug
(Figures 6B, 7A). Reduction in the labile zinc pool was previously
observed in A. fumigatus, Fusarium, and C. albicans treated
with antimalarial drugs such as atovaquone and halofantrine
(Simm et al., 2011; Clark et al., 2018). However, no reduction
in total zinc accumulation could be detected in Candida under
these conditions. These findings are similar to the result in
this study where the total zinc accumulation did not change
upon treatment with artemisinin. This may seem contradictory
regarding the increase in fluorescence seen for the Zrt2prom-
GFP and Zrt2prom-dTomato promoter-reporter constructs. The
zinc sensor is sensitive to the available or labile zinc concentration
that can be used in biological processes, rather than the total
zinc concentration. Since a reduction in the labile zinc pool
could be measured, we believe that artemisinin changes the
availability of labile zinc while total zinc concentrations remains
unchanged. The drug might interfere with compartmentalization
or remobilization of the intracellular zinc pool or affect zinc
chelation. In those events the intracellular labile zinc would not
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be accessible, and the cell would sense zinc deficiency which in
turn would trigger transcription of zinc responsive genes such
as ZRT2.
The second lead compound, pyrvinium pamoate, is an
anthelmintic effective for the treatment of pinworms but
repurposing strategies have revealed its potential in cancer
therapy (Momtazi-borojeni et al., 2018). Pyrvinium pamoate
did show an adverse effect on metabolic activity in A549
cells at concentrations higher than 2.5µM (Figure 5),
however, it has been approved by FDA for the safe use in
humans and is used as a therapeutic with few side effects.
The drug is thought to interfere with glucose uptake
but also contributes to the inhibition of mitochondrial
respiration complex 1 (Sheth, 1975; Ishii et al., 2012).
Recent advances in cancer therapy revealed that pyrvinium
pamoate suppresses the Wnt signaling cascade (Li et al.,
2014). No reference to metal binding or interfering with
metal regulatory processes could be found but our data
strongly suggest its involvement in zinc and iron homeostasis
(Figures 6A,B, 7B).
Both artemisinin and pyrvinium pamoate show fungistatic
rather than fungicidal properties [Supplementary Table 1,
(Siles et al., 2013)]. For this reason, both compounds will
only be effective in adjunct (ideally synergistic) therapy
with known antifungals such as azoles. Synergistic drug
combination is a promising alternative approach to discover
drugs with unexploited chemical scaffolds and a unique
mechanism of actions. Synergism can potentially reduce
the dose of single drug usage with increased drug efficacy,
and subsequently lower the drug toxicity and development
of drug resistance. De Creemer et al. conducted a high
throughput screen for miconazole potentiators against C.
albicans biofilm formation and identified both artemisinin
derivatives and pyrvinium pamoate as candidate molecules
(De Cremer et al., 2015). Artemisinins in particular exhibited
highly synergistic efficacy when combined with miconazole.
Similarly, a synergistic effect was found in combination with
itraconazole againstA. fumigatus (Gautam et al., 2011). The black
yeast Exophiala dermatitidis was treated with a combination
of pyrvinium pamoate and itraconazole, posaconazole, or
voriconazole and synergistic effects could be observed for
all three combinations (Gao et al., 2018). Several studies
on adjunct treatment of metal chelators, such as EDTA,
dibromoquinoline, or DIBI, and azoles showed markedly
reduced susceptibility of fungi toward these combinations in
comparison with antifungal monotherapy (Casalinuovo et al.,
2017; Mohammad et al., 2018; Savage et al., 2018). While
most of these studies focus on iron metabolism, targeting zinc
homeostasis has also been proven to be a successful strategy
(Cohrt et al., 2018).
Consequently, targeting zinc and iron metabolism opens
up new opportunities for novel therapeutic strategies. The
discovery of small molecules that interfere with iron and
zinc homeostasis will expand the chemical diversity of
antifungals and will lead to enhanced efficacy of currently
administered antifungal drugs. The zinc and iron sensors
established in this work have successfully identified new
chemical entities with antifungal properties. They provide a
strong tool for further antifungal screens and can be easily
adapted to other pathogenic fungi such as Cryptococcus
spp. or Aspergillus spp. Our results invite further studies
on these promoter-reporter constructs to explore metal-
dependent activation within phagocytes. Compounds that
increase depletion of iron or zinc in pathogenic fungi inside
macrophages or neutrophils could facilitate increased killing
and clearance.
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